DENNIS MUNGALL, PHARM. D.
7732
Quarry Cliff Ct
Reynoldsburg ,
OH 43068
Phone (Cell) : 614-571-0111
E-Mail: Thertch@aol.com,
www.clinpharmacologist.bigstep.com
MISSION
My missions is to assist in improving patient care
VISION
Be involved in challenging and innovative endeavors in healthcare that
involve management, development, and implementation of novel methods of
healthcare delivery
PRESENT POSITION
(2000-present)
Director, Virtual Education, Associate Professor, Pharmacy
Practice,Ohio State University , College of Pharmacy
Columbus , Ohio
Responsibilities:
· Developed from “the ground up” the first completely internet based Professional program at OSU (Doctor of Pharmacy, www.osuntpd.com)
· Currently have 4 classes enrolled with 140 students from US and 5 foreign countries, 28 graduates
· Responsible for mentoring students research projects (115 clinical projects)
· Course Director for All Therapeutics Classes
· Lecturer in Thromboembolic Disease, Cardiovascular Disease, Pain Management, Clinical Pharmacokinetics, General Clinical Pharmacology, Depression , Anxiety
· Manage development and administrative group responsible for the Non Traditional Doctor of Pharmacy Program
· Developed Virtual Educational Training Rotation
· Responsible for Live , internet case based workshops using a virtual classroom ( www.elluminate.com)
Skills:
Substantial background adult education, internet based educational platforms, computer hardware, multimedia hardware and software, in multimedia development, internal medicine, ambulatory and hospital based clinical pharmacology, pharmacokinetics, clinical research, communication skills, and project management skills.
Other EXPERIENCE
1994-2000 Associate Director of Clinical Pharmacology and Research
Family Practice Residency, Tallahassee Memorial Healthcare
Responsibilities:
· Developed and directed clinical research unit in the family practice residency
· Developed and ran anticoagulation clinic in FP
· Clinical Pharmacology attending on the inpatient service , daily rounding
· Clinical Pharmacology attending in the FP clinic
· Teaching role with medical students , FP residents, Pharm.D. students
·
1994 -2000 Adjunct AssociateProfessor of Clinical
Pharmacy
University of Florida , 1995-2000
,Adjunct Associate Professor of Medicine
University Of South Florida
· FP member on the P and T committee at TMRMC
· Developed outpatient formulary system
· Developed indigent care program to supply medications
1987 - 1994 Associate Professor of Clinical Pharmacy, Tenured
Ferris State University
· Developed Practice site at Ingham Medical Center, Lansing Michigan
· Participated in Mulitcenter trials
· Taught BS students on clinical rotations
· Participated in university committees
1984 - 1987 Clinical Research Director, 1st Employee, Startup Company
Developed the First Patient Side Whole Blood PT and APTT test
Biotrack Inc., Mountain View, CA
· Directed all the clinical trials for the first patient side , whole blood INR device
· Saw my idea for a product become used worldwide
· Developed a software system for modeling warfarin therapy
· Acted as Principal Investigator on an NIH grant to develop a heparin modeling system
1983 - 1984 Senior Research Scientist
Syva/Syntex Diagnostics, Palo Alto, CA
· Worked on clinical trials for diagnostic products such as chlymidia, GC, Herpes
· Worked on the first Bayesian forecasting system for therapeutic drug monitoring ( Predictor System )
1981 - 1983 Clinical Research Fellow/Clinical Pharmacology
University of Texas, Austin and San Antonio, Texas
· Worked with Dr Tom Ludden to perform the first prospective population kinetics trial ( warfarin ) to utilize the NONMEM system
· Daily rounds on the inpatient service , attending in clinical pharmacology
· Developed HPLC , TLC, ultracentrifigation methods for analyzing total and free warfarin concentrations
· Worked on multiple other projects including hydralazine kinetics, gold kinetics
1978 - 1981 Assistant Professor of Pharmacy
Samford University, Birmingham, AL
· Taught didacitic courses in therapetics and kinetics
· Taught BS , medical students, residents on clinical rotation the the VA Medical Center
· Established an anticoagulation clinic with a hematologist , Dr Man Chu Poon
· Established a Pulmonary clinic
· Established a clinical pharmacokinetic service
· Rounded daily on the internal medicine service
· Developed clinical research grants and implemented these
1977 - 1978 Clinical Pharmacist
University of Alabama, Birmingham, AL
· First Clinical Pharmacist at UAB
· Developed an internal medicine service
·
Developed a clinical pharmacokinetics service for Burn
Patients
TEACHING
Ohio State University :Course Coordinator NTPD :
Therapeutics 777d, 778D,779D,780D,781D, 782D, 700D
Lectures in Clinical Pharmacokinetics, Workshops in all courses
Ohio State University College of Pharmacy
Non Traditional Doctor of Pharmacy Program
2000-present
TMRMC Attending , Clinical Pharmacology
Medical Residency Program
Tallahassee Memorial Regional Medical Center
Family Practice Residency Program
Clinical Pharmacology Lectures
Medical Residency Program
TMH
Infectious Disease
Thrombosis and Anticoagulation
Congestive Heart Failure
Depression
Allergy
Pharmacokinetics and Dynamics
Geriatric Pharmacology
Congestive Heart Failure Lectures
University of Florida
Doctor of Pharmacy Program, May 1998
Internal Medicine/Clinical Pharmacokinetics
Rotation
Doctor of Pharmacy Students
University of Florida
1994 -2000
Ferris State
University
Course Director
Clinical Pharmacokinetics
Doctor of Pharmacy Program, Ferris State University
Clinical Kinetics of Heparin, Phenytoin, and
Warfarin Clinical
Kinetics Course
Therapeutics
Course :
Thrombolytic Therapy , Hemostasis and Thrombosis
Doctor of Pharmacy Program ,Ferris State University
Internal Medicine/Pharmacokinetics Rotation
Ferris State University
1987
- 1993
Attending Clinical
Pharmacology, Internal Medicine Service
Ingham Medical Center
1987 - 1993
Internal Medicine Service, Medical Center Hospital
San Antonio, Texas, 1983 - 1983
Treatment of Congestive Heart Failure
Doctor of Pharmacy Program
University of Texas, 1981
Treatment of Thromboembolic Disorders
Doctor of Pharmacy Program
University of Texas, 1981
Attending Clinical Pharmacology, Internal Medicine
Service
Birmingham VA Medical Center 1981 - 1982
Assist Professor of Clinical Pharmacy, Samford
University
Applied Clinical Pharmacokinetics (1 hr course)
Biopharmaceutics and Pharmacokinetics (3 hr course)
Pulmonary Therapeutics GI Therapeutics Hematology
1979 - 1982, Samford University College of Pharmacy
EDUCATION
1981 - 1983 Clinical Research Fellowship
Advisor: Thomas Ludden, Ph.D.
University of Texas College of Pharmacy
1976 - 1977 Doctor of Pharmacy
Advisor: John G. Wagner, Ph.D.
University of Michigan
College of Pharmacy
1975 - 1976 Hospital Pharmacy Residency
Advisor: Jack Upton
Moses Cone Hospital
Greensboro, NC
1969 - 1975 Bachelor of Science
University of Michigan
College of Pharmacy
College of Literature, Science, and
Arts
SERVICES INITIATED
Clinical Pharmacy Services
University of Alabama, 1977
Burn Service Clinical Kinetics Service
University of Alabama, 1978
Outpatient Anticoagulation Service
Drug Monitoring Service for Respiratory Patients
VA Medical Center
Birmingham, Alabama, 1979
Inpatient Clinical Pharmacology/Kinetics/Teaching Service
Ingham Medical Center
Lansing Medical Center, 1988
Inpatient/outpatient Clinical Pharmacology Service
Tallahassee Memorial Healthcare
Tallahassee, FL, 1994
Inpatient Heparin Management Service
CCU/CPCU, 1995
Tallahassee Memorial Healthcare
Inpatient/Outpatient Anticoagulation Service
Family Practice Residency
Tallahassee, FL 1995
PROFESSIONAL ORGANIZATIONS
American College of Clinical Pharmacy
Ohio Pharmaceutical Association
American Society of Clinical Pharmacology and Therapeutics
Vice President, Board of Education , of a virtual K- 12 school , VCS Ohio ( www.vcslearn.org)
CURRENT LICENSURE
Ohio , Florida, Michigan
PATENTS
Integrated Drug Dosage Form and Meter
Patent #4, 712,460, December 15, 1987
SOFTWARE PROGRAMS
· Warfcalc: A computed program for managing warfarin therapy.
Mungall D, Program designer and developer
· Drug Calc And DrugCalc for Windows: A General Pharmacokinetic and Dynamic Program for managing drug therapy.
· Warfarin Hypertext, Mungall D
· C.O.A.G. Expert, Computerized Optimal Anticoagulation Guide, Mungall D
· Anticoagulation and Thrombolytic Multimedia, Hypertext Program, Mungall D
· The Virtual Anticoagulation Clinic : Internet based management of patients receiving warfarin
· WarfDocs : A palm based warfarin management program
CD ROMS:
· The Virtual Congestive Heart Failure Clinic.
· The Virtual Hypertension Clinic
· The Virtual Anticoagulation Clinic
· The Virtual Obesity Clinic
GRANTS AND AWARDS
1979 Digoxin-Quinidine Interaction, Annual Roche Award
1978 Impact of clinical Pharmacokinetics Service on Patient OutcomesSchering Corp.
1983 Diltiazem-Warfarin Interaction, Marion Laboratories
1985 A System for Managing Heparin Therapy, NIH Grant,Principal Investigator
1988 An Evaluation of the Pharmacokinetics and Pharmacodynamics
of tissue Plasminogen Activator Faculty Research Grant, Pharmaceutical
Manafacturers Association
1990 A Cost Effective Stragedy for Obtaining Aminoglycoside Concentrations (MSHP Research Award)
1991 A Randomized Trial of LMWH versus Warfarin in Orthopedic
Patients, Wyeth-Ayerst
1991: Randomized Trial of Logiparin versus Heaprin in Deep venous Thrombosis, Novo Pharmaceuticals
1991 Developing a Multimedia, Expert System for Anticoagulation,
NIH Grant, PI
1992 Multicenter Trial of Computer Assisted Heparin Therapy Versus
Physician Directed Heparin Therapy, Supported by Genentech
1995-Present MAK - Anti-TNF Sepsis Trial, Knoll Pharmaceutical Co.
Praise II Trial Congestive Heart Failure, Pfizer
Let Trial Hypertension Trial, Merck
Whole Blood APTT Trial, Gensia Sicor
LIFE Hypertension Trial, Merck
ALLHAT, NIH Hypertension Trial
The anticoagulation Clinic without walls: American Heart Assoc.1998
Developing Learning Objects : Ohio Board of Regents 2002
COMMITTEES ;
Current Committees at OSU College
of Pharmacy:
Mission , planning , and assessment sub committee
Curriculum self study committee
NTPD admissions committee
Portfolio evaluation committee
2003- present
Primary Care Research Institutes
Board, OSU
Chairman,
Research Committee
Family Practice Residency Program
1994-2000
Curriculum Committee:Family Practice Residency Program 1994-2000
Computer
Committee 1994-2000
Family Practice Residency Program
Pharmacy and Therapeutics Committee, Tallahassee Memorial Healthcare 1994-2000
Anticoagulation Subcommittee, Tallahassee Memorial Healthcare 1994-2000
Congestive
Heart Failure Pathway Committee, Tallahassee Memorial Healthcare 1994-2000
PUBLICATIONS
Stewart, C., Mungall, D., Dimick, A. Ecthyma Gangrenosum. Drug Intell
Clin Pharm.
13:692-695, 1994.
Mungall, D., Robichaux, R., Perry, W., Scott, J., Robinson, A., Hurst, D. The Interaction between Digoxin and Quinidine. Annal of Internal Medicine, 93:689-693, 1980.
Mungall, D. Pharmacokinetics: An Introduction. Alabama J Pharmacy, 1:105, 1980.
Robinson, A., Poon, M., Mungall, D. Quantitation of Plasma Warfarin by HPLC. The Drug Monit, 3:287-290, 1981.
Mungall, D., Marshall, J., Bancroft, W. Computer Assisted Oral and
Intravenous Theophylline
Therapy. Computer and Biomed Res, 15:18-28, 1982.
Mungall, D., et al. Individualizing Theophylline Therapy: The Impact of Clinical Pharmacokinetics on Patient Outcomes. The Drug Monit, 5:95-101, 1983.
Mungall, D., Wong, YY., Talbert, R., Crawford, M., Ludden, T. Plasma Protein Binding of Warfarin: Methodological Considerations. J Pharm Sci, 73:1000-1001, 1984.
Mungall, D., Talbert, R., Jaffe, A., Ludden, T. Sucralfate-Warfarin
Interaction. Annala of
Internal Medicine, April 1983.
Mungall, D., Ludden, T., Hawkins, D., Tabor, T., Penn, D., Crawford, M.
Effect of Diltiazem
on Warfarin Plasma Protein Binding. J Clin Pharmacol, 24:264-266, 1984.
Wandell, M., Mungall, D. Computer Assisted Drug Interpretation and Drug Regimen Optimization. American Association for Clin Chem, 6:1-11, 1984.
Mungall, D., Ludden, T., Marshall, J., Crawford, M., Hawkins, D.
Relationship Between
Steady-State Warfarin Concentrations and Anticoagulant Effect. Clinical
Pharmacokinetics, 9:99-100, 1984.
Svec, J., Coleman, R., Mungall, D., Ludden, T. Bayesian
Pharmacokinetic/Pharmacodynamic
Forecasting of Prothrombin Response to Warfarin Therapy: Preliminary
Evaluation.
Ther Drug Monit, 7:174-180, 1985.
Mungall, D., Ludden, T., et al. Population Pharmacokinetics of Racemic Warfarin. J Pharmacock Biopharm, 13:213-226, 1985.
Hong, R., Murray, W., Coleman, R., Mungall, D. Computer Assisted Warfarin Therapy. Proceedings of he Congress on Medical Infomatics, 3:3100-314, 1985.
Murray, B., McWaters, D., Coleman, R., Ludden, T., Mungall, D.
Pharmacodynamics of Warfarin
Clin Pharm Ther, 37:215, 1985. (abst)
White, RH., Hong, R., Venook, A., Daschbach, M., Murray, W., Coleman, R., Mungall, D. Initiation of Warfarin Therapy: Comparison of Physician Dosing to Computer-Assisted Dosing. J General Internal Medicine, 2:141-148, 1987.
Murray B., Coleman, R., McWater, D., Ludden, T., Mungall, D.
Pharmacodynamics of Warfarin
at Steady State. Ther Drug Monit, 9:1-5, 1987.
Lucas, F., Coleman, R., Jay, R., Duncan, A., Hirsh, J., Mungall, D.
Multicenter Evaluation of a
Novel Capillary, Whole Blood Prothrombin Time Device. Amer J Clin Path,
88:442-446, 1987.
Ludden, TM., Mungall, DO., Raskob, GE., Hull, RD. A Mixed Effects Model for Heparin Pharmacokinetics and Pharmacodynamics. Clin Pharm Ther, 41:176 (Abstract, 1987).
Mungall, D., Ludden, TM., Raskob, GE., Lopez, D., Hull RD. Bayesian
Pharmacokinetic/
Pharmacodynamic Forecasting of APTT Response to Heparin Therapy in Patients
WithVenous Thrombosis. Clin Pharm Ther, 41:177 (Abstract, 1987).
Lee, C., Coleman, R., Mungall, D. Effect of Using Warfarin Plasma
concentrations in Bayesian
Forecasting of Steady-State Prothrombin time Response. Clin Pharm,
6:406-412, 1987.
Mungall, D., Floyd,R. The Effects of Warfarin on the Activated Partial
Thromboplastin Time.
J Clin Pharmac, 28:934, 1988.
Mungall, D., et al. Population Pharmacokinetics of Heparin. J Clin Pharm, 29:1043-1047, 1989.
Farrow, L., Mungall, D., Raskob, G., Hull, R. Predicting Daily Response To
Warfarin. Ther
Drug Monitor, 12:246-249, 1990.
Bubp, J., Coleman, R., Mungall, D., Raskob, G., Hull, R. Comparison of Warfarin Pharmacodynamic Predictions using Manchester Reagent. Clin Pharm Ther, 47:157,(abstract) 1990.
Mungall, D. Update on Thrombolytic Therapy. Emergency Cardiac Care, 1:1-2, August 1990.
Porter, S., Mungall, D. Fresh Whole Blood Clot Lysis Time as a Measure of
the Modulating
Effects AAG on TPA Response. Fibrinolysis, 4:315m 1990.
Mungall, D., et al. Predicting Pharmacodynamic Response to TPA. Ther Drug Monit, 13:402, 1991.
White, R., Mungall, D. Outpatient Management of Warfarin Therapy: Comparison
of
Computer-Predicted Dosage Adjustment to Skilled Professional Care. Ther Drug
Monit, 13:46, 1991.
White, RH., Mungall, D., et al. Treatment of Proximal Deep Vein Thrombosis
using
Subcutaneously Administered Calcium Heparin. Hemostasis, 22:129-137,
1992.
RD Heparin Group, Efficacy and Safety of RD Heparin Versus, Warfarin for
Prevention of DVT
after Hip or Knee Replacement. Blood, 78:187a, 1991.The Journal of Bone
and Joint Surgery 1994;76:1174-1185.
White, R., Mungall, D. Heparin Therapy in Patients Treated with TPA. New
England Journal of
Medicine, 324:1217 Letter to the Editor, 1992.
Kershaw, B., White, R., Mungall, D., et al. Computer Assisted Dosing of
Heparin: Management
Using A Pharmacy Based Service. Archives of Internal Medicine, June
1994.
Mungall, D., Amby, D., Forrester, P., et al. A prospective Randomized
Comparison of Computer
Assisted Versus GUSTO nomogram Directed Heparin Therapy. Clin Pharm and
Therapeutics, 55:591-596, 1994.
A Strategy for Implementing A Computer Assisted Anticoagulation Service, Mungall, D Treadwell, P., ., et al. Presented, Southeastern Residents Conference, Athens, GA,April 6, 1995.
Changes in Plasma Warfarin Levels and Variation in Steady State Prothrombin
Times.
White, RH., Mungall, D., Zhou, H., Romano, P. Accepted: Clinical Pharmacology
and Therapeutics, April 1995.
Developing a System for Continually Improving Intravenous Heparin Therapy in
Cardiovascular Patients , American Society of Hematology, December 1996,
Orlando Fl
White RH, Zhou H, Mungall D.
Effect of weight , Sex, Age , Clinical Diagnosis, and Thromboplastin Reagent on
Steady-State Intravenous Heparin requirements. Arch Intern Med 1997;
157:2468-72
Mungall D, Lord M, Cason S et al. Developing a System to
Improve the Quality of Heparin Therapy in patients with acute
coronary syndromes. American J Cardiology , Sept 1998.
Mungall D, Baltadono L, Watson D.
Management of a Patient with Atrial Fibrilation and Factor VII Deficiency.
Annals of Pharmacotherapy , June 1998.
Mungall D.
Activated partial thromboplastin time vs heparin concentration.
Archives of Internal Medicine 1998; 158:1273-1275.
Casimiro J, Mungall D. Patient Oriented , Technology Based Anticoagulation
Clinic
Computers and Medicine May 1998.
Motykie G, Caprini J, Mungall D.
Computer Assisted Warfarin versus Standard Warfairn in Hip Replacement
Patients
J Arthroplasty , Accepted Pub. May 1999
Mungall,D. Desmin 370. Current Opinion in Cardiovascular, Pulmonary , and Renal
Investigational drugs. 1999:1(1) :99-103
Mungall D. rNAPc2 Review. Current Opinion in Cardiovascular, Pulmonary, and Renal Investigational Drugs 2000 2:160-164
Mujngall, D.Evaluation of a new Thrombin Inhibitor, BIBR953ZW for Thromboembolic Disease Current Opinion Investigational Drugs 2002 3:8-10
Mungall, D. rNAPc2 Nuvelo.
Current Opinion in Investigational Drugs. 5(3): 2004
PRESENTATIONS
12-4-77 Establishing Clinical Pharmacy Services in a Medical Intensive
Care Unit. ASHP Midyear Clinical Meeting
1-10-79 Review of Basic Pharmacokinetic Principles, Southern Regional
Medical Education Center, Birmingham, AL
1-10-79 Practical Applications of Pharmacokinetics: Theophylline
Southeastern Regional Medical Education Center,
Birmingham, AL
3-25-78 Aminoglycoside Pharmacokinetics, Alabama Society of Hospital
Pharmacists, Birmingham, AL
5-14-81 Theophylline Pharmacokinetics, Maryland Society of Hospital
Pharmacists, Baltimore, MD
2-79 Digoxin Intoxication, Presented at Childrens Hospital, Birmingham, AL
11-83 Cimetidine, Presented at the California Association of Toxicology
10-24-86 A Computer Aided Approach to Anticoagulant Therapy,
Pharmacokinetics Conference, Madison, WI
3-87 Bayesian Pharmacokinetic/Pharmacodynamic Forecasting of APTT Response
to Heparin Therapy in Patients with
Venous Thrombosis, Presented at the 88th Annual Meeting of the Society for Clinical
Pharmacology and Therapeutics
11-88 The Effect of Warfarin on APTT Response, The American College of Clinical Pharmacology Meeting, Orlando, FL
12-88 The Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen
Activator, Presented at the American Society
Of Hospital Pharmacists, Dallas, TX
2-17-89 Pharmacokinetics and Pharmacodynamics of Anticoagulants, Michigan Pharmaceutical Association
10-26-89 In-Vitro Evaluation of the Pharmacodynamics of Tissue Plasminogen
Activator, Presentation: 18th
European Symposium on Clinical Pharmacy,Nijmegen, The Netherlands
10-4-89 Anticoagulation, MSHP Meeting
3-21-90 Comparison of Warfarin Pharmacodynamic Model Predictions
Using Manchester Comparative Reagent vs. Simplastin
Reagent, Presented at the 91st Annual Meeting of the
American Society of Clinical Pharmacology and Therapeutics, San Francisco, CA
3-90 Pharmacokinetics and Pharmacodynamics of Anticoagulants,
Hematology Medicine Conference, UC Davis Medical
Center, Sacramento, CA
8-90 Whole Blood Clot Lysis Time as a Measure of the Modulating
Effects of Alphal Acid Glycoprotein (AAG) and Aspirin on
The rt-PA Response, Tenth International Congress on
Fibrinolysis, Indianapolis, IN
12-6-90 Predicting Aminoglycoside Serum concentrations in a Cystic Fibrosis
Forecasting, Presented at the 25 th ASHP
Annual Midyear Clinical Meeting, Las Vegas, NV.Michigan Society of Hospital
Pharmacists, 2-9-91
10-15-90 Novel Methods for Monitoring Thrombolytic Therapy, Presented
At the Hematology Conference, University of Guistenberg, Center for Thrombosis
and vascular Research,
Leuven, Belgium
4-92 Computer Strategies for Anticoagulation, Society of General Internal Medicine, Washington, DC
2-21-93 Multimedia: Windows of Opportunity for Medicine, Michigan Pharmaceutical Association
4-25-93 Individualizing Anticoagulant Therapy, Southfield, MI
4-29-93 A Pharmacy Based Anticoagulation Service, Society of General
Internal Medicine, Arlington, VA
4-24-93 Computer Assisted Anticoagulation, Lutheran Regional Medical Center, Grand Rounds
5-95 Myths in Anticoagulation
Conference on Anticoagulation
Tallahassee Memorial Regional Medical Center
7-95 Overview of Anticoagulation Therapy
Georgia Society of Physicians Assistants. St Simon Island
3-96 Allergic Rhinitis
Valdosta Ga Medical Association
11-96 Developing a System to Continually Improve
The Quality of Heparin Anticoagulation In Cardiovascular Patients.
American Society of Hematology
November 1996, Orlando Fl
5-6-97 Prospective Analysis of a Patient Oriented,
Technology based Family Practice Anticoagulation
Clinic, Anticoagulation Forum, 4th, San Antonio Texas, 1997.
12-7-97 Cost Evaluation of Oral Levofloxacin compared to conventional
Intravenous therapy in hospitalized patients treated for community
Acquired pneumonia American Society of Hospital Pharmacist, Atlanta , Dec 1997.
4-21-98 A Smorgasbord Approach to Cardiovascular Clinical Pharmacology
Cardiology Grand Rounds, Tallahasee Memorial Healtcare, Tallahassee Fl
4-15-99 Mysteries of Anticoagulation
American Lung Association Annual Meeting
Tallahasse, Fl
5-15-99 Anticoagulation Clinic Without Walls
Anticoagulation Forum: Vancouver Canada
10-1-01
WebNet 2001: Challenges of Creating an Online Doctoral Program: Panel Discussion of the Trials and Success of the Ohio State NonTraditional Doctor of Pharmacy Program
11-7-01 “The Virtual Anticoagulation Clinic”
, Oncology Research Conference, Ohio State University
2001-Weaving a World Wide Education
AACP Meeting , Toronto Canada 2001
2002-A Pharmaco-Illogic Approach to evaluating Drug Therapy
Family Practice Conference, Rardin Center, OSU
10-29-03 Weaving Your Way Through the Medical Web
Annual Pediatric Nurses Conference, Childrens Hospital, Cincinnati OH
7-10-04 American Association of Colleges of Pharmacy,
Development and
Implementation of a Virtual Advanced Teaching Experience.
Maria Pruchnicki, Julie Legg, Marialice Bennett, Dennis Mungall. The Ohio State University College of
Pharmacy.
BOOKS
Mungall, D., Editor
Applied Clinical Pharmacokinetics
Raven Press, 1983.
Pharmacokinetics: An Introduction, Mungall, D., Docktor W
Theophylline Pharmacokinetics, Mungall D.
Computer Programs in Pharmacokinetics , Mungall D, Bowman D.
Mungall D, Computer Applications in Clinical Pharmacokinetics
Therapeutic Drug Monitoring, CRC Press, 1995.
Mungall, D., White RH.
Pharmacodynamics of Anticoagulants
CRC Press, 1995.
Mungall D, Oertel L
Computer Applications In Anticoagulation
In : Managing Oral Anticoagulation: The Development of an Anticoagulation
Management Service ,Aspen Publishing, 1996
Managing Oral Anticoagulation Therapy: Clinical and Operational
Guidelines, Aspen Press
Software Applications in Anticoagulation Management
Editor, Ansell J 2002